Specifically, they are approved in patients who have a BMI 30 kg/m 2 or who have a BMI 27 kg/m 2 and an obesity-related health condition (eg, diabetes, hypertension, or dyslipidemia)
GLP-1 is the familiar part of the design
Each lot is HPLC-tested for purity and confirmed by mass spectrometry
Preclinical and limited clinical research suggests Epitalon could improve lifespan, reduce age-related diseases, and enhance overall cellular function
For safety reasons, it is recommended that patients stop GLP-1 drugs at least 2 weeks before surgery
The brand doesn't publish individual lot test results on a public certificates-of-analysis page in the way some supplement brands do - buyers who want COA documentation should contact NativePath customer support directly